Evidence map›Paper›PMID 30159809›Full record

ArticleIndian journal of pediatrics2019

Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.

Jing Jin, Jing Wang, Yadong Lu, Zhidan Fan, Na Huang, Le Ma, Haiguo Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Vitamin D and Kawasaki disease.Frontiers in pharmacology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Platelet-Derived Microparticles and Autoimmune Diseases.International journal of molecular sciences · 2023
    Review
  12. [Proteomics of serum exosomes in children in the acute stage of Kawasaki disease: a prospective study].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jing JinChildren's Hospital of Nanjing Medical University, Nanjing, China.
Jing WangNanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, China.
Yadong LuChildren's Hospital of Nanjing Medical University, Nanjing, China.
Zhidan FanChildren's Hospital of Nanjing Medical University, Nanjing, China.
Na HuangChildren's Hospital of Nanjing Medical University, Nanjing, China.
Le MaChildren's Hospital of Nanjing Medical University, Nanjing, China.
Haiguo YuChildren's Hospital of Nanjing Medical University, Nanjing, China. yuhaiguo73@126.com.ORCID http://orcid.org/0000-0002-1115-238X
Second Affiliated Hospital of Nanjing Medical University · CNNanjing Children's Hospital · CNTongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the dynamic changes of platelet-derived microparticles (PDMP) in Kawasaki disease (KD) and its clinical significance and to study its relationship with intravenous immunoglobulin (IVIG) resistance, inflammatory indicators and aspirin treatment in children with KD.

methodsTwenty children with KD were enrolled as the experimental group, while 20 age- and gender-matched children with common febrile disease were included in the control group. Blood samples were drawn before and 7-10 d after IVIG infusion and thereafter at 1, 2, and 3 mo after the onset of KD to estimate the PDMP concentrations by enzyme linked immunosorbent assay (ELISA). C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), and cytokines [Interleukin-6 (IL-6), Tumor necrosis factor-α (TNF-α), and Soluble interleukin-2 (sIL-2R)] were also measured.

resultsThe level of PDMP in KD children before IVIG was significantly higher than that in controls (P < 0.0001). The PDMP level in KD children decreased significantly at 7 to 10 d after IVIG (P < 0.0001) and then decreased to the lowest level in the course of 1 to 2 mo. Some children's PDMP level rebounded in the course of 3 mo (P = 0.047). In addition, the mean level of PDMP in IVIG-resistant children was higher than that in IVIG-effective children; however, there was no significant difference between the two groups (P = 0.1945). Furthermore, PDMP was positively correlated with hs-CRP, IL-6, and sIL-2R levels, but no correlation was observed with ESR, PCT, and TNF-α levels.

conclusionsPDMP can be used as an index to monitor inflammation in children at the acute stage of KD. And the duration of platelet activation in KD is individualized.

Indexed as

Blood PlateletsCell-Derived MicroparticlesInflammationPlatelet ActivationAspirinBiomarkersBlood SedimentationChild, PreschoolC-Reactive ProteinCytokinesFemaleHumansImmunoglobulins, IntravenousInfantMaleMucocutaneous Lymph Node SyndromeAspirinBiomarkersC-Reactive ProteinCytokinesImmunoglobulins, IntravenousInflammationKawasaki diseasePlatelet activationPlatelet-derived microparticle

Identifiers

PMID30159809
OpenAlexW2889273493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.